Jiangsu Chinagreen Biological Technology Co.,Ltd. Stock

Equities

300970

CNE100004KF5

Fishing & Farming

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
13.18 CNY +5.19% Intraday chart for Jiangsu Chinagreen Biological Technology Co.,Ltd. +8.57% -23.64%
Sales 2022 752M 104M Sales 2023 996M 138M Capitalization 2.03B 281M
Net income 2022 78M 10.77M Net income 2023 30M 4.14M EV / Sales 2022 2.44 x
Net cash position 2022 242M 33.45M Net cash position 2023 76.62M 10.58M EV / Sales 2023 1.97 x
P/E ratio 2022
26.6 x
P/E ratio 2023
66.4 x
Employees 2,408
Yield 2022
1.12%
Yield 2023
1.16%
Free-Float 46.13%
More Fundamentals * Assessed data
Dynamic Chart
Jiangsu Chinagreen Biological Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Jiangsu Chinagreen Biological Technology Co.,Ltd.'s Equity Buyback Plan announced on March 4, 2024. CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. authorizes a Buyback Plan. CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. Announces Directorate Appointments CI
Jiangsu Chinagreen Biological Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Hualv Biological Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chinagreen Biological Cancels Planned $40 Million Factory Upgrade MT
Jiangsu Hualv Biological Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangsu Hualv Biological Technology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangsu Chinagreen Biological Technology's Shareholders Plan to Cut 6% Stake CI
Jiangsu Hualv Biological Technology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day+5.19%
1 week+8.57%
1 month-4.84%
3 months+6.81%
6 months-26.12%
Current year-23.64%
More quotes
1 week
12.13
Extreme 12.13
13.64
1 month
10.70
Extreme 10.7
13.81
Current year
9.27
Extreme 9.27
17.49
1 year
9.27
Extreme 9.27
24.67
3 years
9.27
Extreme 9.27
34.97
5 years
9.27
Extreme 9.27
50.00
10 years
9.27
Extreme 9.27
50.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 10-06-07
Chairman 36 11-05-31
Director of Finance/CFO 38 13-01-31
Members of the board TitleAgeSince
Director/Board Member 52 17-06-13
Director of Finance/CFO 38 13-01-31
Chief Executive Officer 53 10-06-07
More insiders
Date Price Change Volume
24-04-30 13.18 +5.19% 6,295,791
24-04-29 12.53 +3.21% 1,729,100
24-04-26 12.14 -0.65% 1,449,500

End-of-day quote Shenzhen S.E., April 29, 2024

More quotes
Jiangsu Chinagreen Biological Technology Co Ltd is a China-based company mainly engaged in the research and development, factory planting and sales of edible fungi. The Company mainly produces and sells flammulina velutipes and hypsizygus marmoreus (including hypsizygus tessellatus and white beech mushroom). The Company uses a factory model to produce edible fungi. According to the different biological characteristics of each edible fungus, the Company makes comprehensive use of biological engineering technology, engineering equipment technology, ecological environment simulation control technology, automation technology, to create a suitable growth environment for edible fungi, and carries out standardized and intelligent management under controllable environmental conditions.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 300970 Stock